Sphingosine 1-Phosphate Receptor 1 Market

Sphingosine-1-phosphate receptor 1 (S1P receptor 1 or S1P1), also known as endothelial differentiation gene 1 (EDG1) is a protein that in humans is encoded by the S1PR1 gene. S1PR1 is a G-protein-coupled receptor which binds the bioactive signaling molecule sphingosine 1-phosphate (S1P). S1PR1 belongs to a sphingosine-1-phosphate receptor subfamily comprising five members (S1PR1-5). S1PR1 was originally identified as an abundant transcript in endothelial cells and it has an important role in regulating endothelial cell cytoskeletal structure, migration, capillary-like network formation and vascular maturation. In addition, S1PR1 signaling is important in the regulation of lymphocyte maturation, migration and trafficking.

Sphingosine 1-Phosphate Receptor 1 Market contains market size and forecasts of Sphingosine 1-Phosphate Receptor 1 in global, including the following market information:

Global Sphingosine 1-Phosphate Receptor 1 Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Sphingosine 1-Phosphate Receptor 1 Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Sphingosine 1-Phosphate Receptor 1 companies in 2021 (%)

The global Sphingosine 1-Phosphate Receptor 1 market was valued at 3486.4 million in 2021 and is projected to reach US$ 5990.1 million by 2028, at a CAGR of 8.0% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Fingolimod Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Sphingosine 1-Phosphate Receptor 1 include Novartis AG and Bristol-Myers Squibb Company etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Sphingosine 1-Phosphate Receptor 1 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Sphingosine 1-Phosphate Receptor 1 Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Sphingosine 1-Phosphate Receptor 1 Market Segment Percentages, by Type, 2021 (%)

• Fingolimod
• Siponimod
• Ozanimod
• Other

Global Sphingosine 1-Phosphate Receptor 1 Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Sphingosine 1-Phosphate Receptor 1 Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Other

Global Sphingosine 1-Phosphate Receptor 1 Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Sphingosine 1-Phosphate Receptor 1 Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Sphingosine 1-Phosphate Receptor 1 revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Sphingosine 1-Phosphate Receptor 1 revenues share in global market, 2021 (%)
• Key companies Sphingosine 1-Phosphate Receptor 1 sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Sphingosine 1-Phosphate Receptor 1 sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis AG
• Bristol-Myers Squibb Company